Megan Dover

About

Megan Dover, Partner and Co-founder of CBIV, has in depth experience in impact investing, angel investing, venture advisory, M&A, business strategy and Financial Planning & Analysis. Prior to the launch of the firm, she was a venture advisor to a portfolio of impact first health technology companies and mobilized $46 million in equity and non dilutive capital for the portfolio. Megan has also held senior level roles in corporate finance and strategy for a publicly traded mining and infrastructure company, worked in management consulting for a global consulting firm, been part of an R&D team for a biotech startup and acted as an advisor and angel investor at the Creative Destruction Lab (CDL). Megan obtained her MBA from the Rotman School of Management at the University of Toronto, receiving a Dean’s list ranking. She also earned her Engineering degree with Honours from Queen’s University, specializing in Biomedical Research within Chemical Engineering.

Source (opens in a new tab)